Healthcare Pharma

Julie Schwedock from Takeda Pharmaceuticals speaks about LBPs: What to consider when choosing CDMOs.

Julie Schwedock, PhD is Associate Director of the Microbial Development Team at Takeda Pharmaceuticals.  She leads a cross-functional Pharmaceutical Sciences team for Live Bacterial Products (LBPs) focused on treating dysbiosis of the gut microbiome.  She also heads a functional line group that works on process development for microbial expression systems as well as LPBs.  Prior […]